Harding Loevner LP’s Edwards Lifesciences Corp Position
Does Harding Loevner LP own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 1.45M shares worth $111M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$111M
Q4 2023
Shares
1.45M
% of Portfolio
+0.62%
Quarters Held
15
position exited
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2023 | 1.45M | $111M | +0.62% |
| Q3 2023 | 1.48M | $102M | +0.68% |
| Q2 2023 | 1.69M | $160M | +0.93% |
| Q1 2023 | 2.03M | $168M | +0.95% |
| Q4 2022 | 2.04M | $152M | +0.88% |
| Q3 2022 | 1.83M | $151M | +0.99% |
| Q2 2022 | 1.92M | $183M | +1.13% |
| Q1 2022 | 1.98M | $189M | +1.04% |
| Q4 2021 | 2.11M | $273M | +1.05% |
| Q3 2021 | 2.15M | $243M | +0.97% |
| Q2 2021 | 2.23M | $231M | +0.87% |
| Q1 2021 | 2.24M | $187M | +0.73% |
| Q4 2020 | 2.41M | $219M | +0.91% |
| Q3 2020 | 846 | $68,000 | 0.00% |
| Q2 2020 | 846 | $58,000 | 0.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Harding Loevner LP’s full portfolio or all institutional holders of EW.